Caribou Biosciences Inc. held its annual meeting of stockholders on June 12, 2025. During the meeting, stockholders elected two Class I directors. An amendment to the company's certificate of incorporation to effect a reverse stock split of common stock was approved. Additionally, the adjournment of the annual meeting was approved if necessary, although it was ultimately not required as there was a quorum and sufficient votes for all proposals.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.